Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2025 ▲▼ | Q2 2025 ▲▼ | Change ▲▼ | Q1 2025 ▲▼ | Q2 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Centessa Pharmaceuticals PlcADS | 19,963,157 | 19,963,157 | 0 | $287.07M | $262.32M | 61.40% | -$24.75M |
| Phathom Pharmaceuticals, Inc.(PHAT) | 7,464,572 | 7,464,572 | 0 | $46.80M | $71.59M | 16.75% | +$24.78M |
| Newamsterdam Pharma Company ORDINARY SHARES | 2,869,565 | 2,869,565 | 0 | $58.74M | $51.97M | 12.16% | -$6.77M |
| Rapt Therapeutics Inc | 0 | 2,794,000 | +2,794,000 | $0 | $22.35M | 5.23% | +$22.35M |
| Aura Biosciences, Inc.(AURA) | 3,039,892 | 3,039,892 | 0 | $17.81M | $19.03M | 4.45% | +$1.22M |
| Rapt Therapeutics Inc | 22,352,000 | 0 | -22,352,000 | $27.27M | $0 | — | -$27.27M |